The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.

about

The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.

Item

http://www.wikidata.org/entity/Q51767200

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The two glycolytic markers GLU ...... ear-cell renal cell carcinoma.

@en

The two glycolytic markers GLU ...... ear-cell renal cell carcinoma.

@nl

type

Item

label

The two glycolytic markers GLU ...... ear-cell renal cell carcinoma.

@en

The two glycolytic markers GLU ...... ear-cell renal cell carcinoma.

@nl

prefLabel

The two glycolytic markers GLU ...... ear-cell renal cell carcinoma.

@en

The two glycolytic markers GLU ...... ear-cell renal cell carcinoma.

@nl

P1476

The two glycolytic markers GLU ...... ear-cell renal cell carcinoma.

@en

P2093

Bérengère Dadone

http://www.w3.org/2001/XMLSchema#string

Delphine Borchiellini

http://www.w3.org/2001/XMLSchema#string

Fanny Burel-Vandenbos

http://www.w3.org/2001/XMLSchema#string

Gilles Pages

http://www.w3.org/2001/XMLSchema#string

Jean Amiel

http://www.w3.org/2001/XMLSchema#string

Maeva Dufies

http://www.w3.org/2001/XMLSchema#string

Matthieu Durand

http://www.w3.org/2001/XMLSchema#string

Nathalie M Mazure

http://www.w3.org/2001/XMLSchema#string

P2860

HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.

VHL, the story of a tumour suppressor gene.

Prognostic significance of morphologic parameters in renal cell carcinoma.

Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.

P304

e0193477

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0193477

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jacques Pouysségur

Nathalie Rioux-Leclercq

Damien Ambrosetti

P577

2018-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29481555

http://www.w3.org/2001/XMLSchema#string

P932

5826688

http://www.w3.org/2001/XMLSchema#string